Treatment with rifampicin for Pneumocystis carinii pneumonia.
The role of rifampicin in the treatment of serologically proved Pneumocystis carinii pneumonitis was reported recently from Poland (1). Serum antibody or antigen levels alone provide uncertain evidence as by four years of age two-thirds of normal children may have significant titres (2). We present the first case treated with rifampicin, and proven by open lung biopsy.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D006801:Humans; D007223:Infant; D008168:Lung / Q000473:pathology; D008297:Male; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D012293:Rifampin